GRP
STOK icon

Global Retirement Partners’s Stoke Therapeutics STOK Stock Holding History

Global Retirement Partners’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.11K Hold
35
– – ﹤0.01% 3868
2025
Q3 		$823 Buy
+35
New +$600 ﹤0.01% 3567

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Retirement Partners's STOK Position: Q4 2025 in Review

Global Retirement Partners held its Stoke Therapeutics (STOK) position steady in Q4 2025 at 35 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

Global Retirement Partners first reported a position in STOK in Q3 2025 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold STOK as of Q4 2025.

  • Global Retirement Partners held 35 shares of Stoke Therapeutics worth $1.11K as of Q4 2025.
  • Global Retirement Partners left its Stoke Therapeutics share count unchanged in Q4 2025.
  • Stoke Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3868 holding.
  • Global Retirement Partners first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.